HE CAPACITY TO PRESENT peptides in the context of HLA class I1 molecules to T-cell receptor expressing T lymphocytes is shared by a number of antigen presenting cell types including B lymphocytes.' Presentation of (a1lo)-antigens to T cells is only observed with activated and not resting B ce1kz4 It has been suggested that this is not due to less effective antigenic peptide occupancy of the T-cell receptor, but to a higher level of accessory molecules present on activated than on resting B lymphocyte^.^ Recently, a number of molecules involved in the cognate interaction between T and B lymphocytes have been identified, including the adhesion receptorfligand pairs leukocyte functionassociated antigen-l (LFA-l)/intercellular adhesion molecule-1,2,3 (ICAM-1,2,3)6-8 and LFA-3/CD2,6.739 as well as molecules associated with the B7-and CD40-mediated pathways of costimulation." The B7 family consists of at least two molecules, B7-1/CD80 (formerly called B7)'"'' and B7-2/CD86.14"6 Both antigens are expressed by various antigen presenting cell types, including activated B cells, and will bind to their ligands CD28I7 and CTLA4" on the T cells. Interaction of B cell CD40I9 with its ligand CD40L20-22 on T cells has been found to play an important role in B-cell activation, survival, and differentiation."
Peripheral blood lymphocytes of a patient with follicular Bcell non-Hodgkin's lymphoma (B-NHL) were immortalized in vitro by Epstein-Barr virus (EBV)
HE CAPACITY TO PRESENT peptides in the context of HLA class I1 molecules to T-cell receptor expressing T lymphocytes is shared by a number of antigen presenting cell types including B lymphocytes.' Presentation of (a1lo)-antigens to T cells is only observed with activated and not resting B ce1kz4 It has been suggested that this is not due to less effective antigenic peptide occupancy of the T-cell receptor, but to a higher level of accessory molecules present on activated than on resting B lymphocyte^.^ Recently, a number of molecules involved in the cognate interaction between T and B lymphocytes have been identified, including the adhesion receptorfligand pairs leukocyte functionassociated antigen-l (LFA-l)/intercellular adhesion molecule-1,2,3 (ICAM-1,2,3)6-8 and LFA-3/CD2,6.739 as well as molecules associated with the B7-and CD40-mediated pathways of costimulation." The B7 family consists of at least two molecules, B7-1/CD80 (formerly called B7)'"'' and B7-2/CD86.14"6 Both antigens are expressed by various antigen presenting cell types, including activated B cells, and will bind to their ligands CD28I7 and CTLA4" on the T cells. Interaction of B cell CD40I9 with its ligand CD40L20-22 on T cells has been found to play an important role in B-cell activation, survival, and differentiation."
Functional studies have indicated that some of these molecules may be important for neoplastic B-cell stimulator capacity in mixed lymphocyte reactions (MLR). Expression of ICAM-1 by leukemic B cells has been described to correlate with MLR stimulator ~apacity.'~ Previous reports on the involvement of costimulatory molecules in all0 MLR suggest that B7-1ICDSO is only one of several determinants of stimu-lator capacity by normal B-cell lines." From the study by Jenkins et alZ6 an important function is suggested for the B7-I, as well as LFA-1 and ICAM-I molecules, in allostimulation by malignant B-cell lines. Ranheim and Kipps" and Yellin et a12* recently reported on the essential role of the CD40/CD40L interaction in the induction of B7-1 molecules required for allostimulation by B-cell chronic lymphocytic leukemia (B-CLL) cells. In the former of these studies, the initial contact dependent signal to activate the B-CLL cells was provided by anti-CD3-activated T lymphocytes. The requirement for activated T cells in this system fits in the currently accepted view that the induction of T-celVB-cell interactions involves a bidirectional signaling pathway."
The expression and activated state of adhesion molecules, particularly of LFA-1, have been implicated in the functional activation of T lymphocytes.29"' Whereas T cells have been found to be required for neoplastic B-cell proliferation in vitro" and in vivo,33 little information is available on the regulation of the feedback signaling provided by the neoplastic B cells in their interactions with the T lymphocytes. The availability of clonal populations of resting and activated neoplastic B cells would allow careful examination of the dynamics of accessory molecules involved in B-cell allostimulation as a model for T-celVB-cell interaction. Therefore, we initiated experiments to establish B-cell lines from the neoplastic cells of a patient with follicular B-cell nonHodgkin's lymphoma (B-NHL) as a source of clonal, activated B lymphocytes. Here, we describe the establishment and characterization of these B-cell lines and compare their functional expression of adhesion receptors and costimulatory molecules with that of the neoplastic B-cell population from which they are derived.
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leah, FL); Leu M3 (anti-CD14), from Becton Dickinson (San Jose, CA); MHM6 (anti-CD23), kindly provided by Dr J. Gordon (University of Birmingham, Birmingham, UK); anti-HLA class I and anti-HLA-DR from Dako (Glostrup, Denmark); lH4-0 (anti-CDZO), bear-I (anti-CDllb), R24.3 (anti-HLA-DR), used in depletion experiments together with 123C3 (anti-CD56), kindly provided by Dr R. Michalides (Netherlands Cancer Institute, Amsterdam, the Netherlands); NKI-L7 (anti-LFA-la, CDlla); CLB-LFA111 (anti-LFA-IP, CD18), kindly provided by Dr F. Miedema (CLB); NKI-L16 (anti-LFA-la, CDlla-activation epitope); F10.3 (anti-ICAM-1, CD54), kindly provided by Dr A. Bloem (Academic Hospital Utrecht, Utrecht, The Netherlands); Ts2/9 (anti-LFA-3, CD58). kindly provided by Dr T.A. Springer (Harvard Medical School, Boston, MA); NKI-P1 (anti-CD44); HP113 (anti-VLA4, CD49d), kindly provided by Dr F. Sanchez-Madrid (Hospital de la Princesa, Madrid, Spain); SAM-I (anti-VLA5, CD49e); GoH3 (anti-VLA6, CD49f), kindly provided by Dr A. Sonnenberg (Amsterdam, The Netherlands); 15E8 (anti-CD28), kindly provided by Dr R. van Lier (CLB); B7-24 (anti-B7-1/CDIO), kindly provided by Dr M. de Boer (Innogenetics, Ghent, Belgium); IT2.2 (anti-B7-2/CD86), kindly provided by Dr M. Azuma (Juntendo University School of Medicine, Tokyo, Japan); 89 (anti-CD40), kindly provided by Dr J. Banchereau (Schering Plough France, Dardilly, France); and TRAP1 (anti-CD40 ligand (CD40L)). kindly provided by Dr R. Kroczek (Robert Koch Institute, Berlin, Germany). The fusion protein CTLA4Ig was kindly provided by Bristol-Myers Squibb (Seattle, WA). Human myeloma protein IgGlK and Concanavalin A (Con A) were purchased from Sigma Chemical CO (St Louis, MO). Recombinant interleukin-4 (rIL-4; specific activity 1.2 X lo7 U/mg) was generously provided through Dr J. de Vries by Dr S. Nagabhushan, Schering Plough Corp (Bloomfield, NY).
Cells and media. NS cells were isolated from the peripheral blood of a patient with follicular B-NHL in leukemic phase by Ficoll Hypaque density centrifugation and used after cryopreservation. Thawed cells were washed once in Dulbecco's modified minimal essential medium supplemented with 10% fetal calf serum (GIBCO Biocult, Glasgow, Scotland), then washed and resuspended in Iscove's medium (Flow Laboratories, Irvine, Scotland) supplemented with 5% pooled, inactivated human serum (CLB, Amsterdam, The Netherlands), penicillin 100 IE/mL and kanamycin 100 pg/mL (used as culture medium in proliferation assays). NS cells were obtained from the patient before, 1 month after, and 1 year after treatment with MoAB anti-CD19.35 All three NS samples were derived of the same cell clone as shown by Southern blot analysis (see below) and reactivity with the anti-id MoAb NI2 and N13 (see Fig 2 for pretreatment NS cells, other data not shown). NS cells obtained 1 month and 1 year after anti-CD19 MoAb therapy were used for electron microscopy and Epstein-Barr virus (EBV) transformation, respectively. Phenotypic and functional analyses were performed with pretreatment NS samples, whereas posttreatment NS samples gave comparable results (data not shown).
Mononuclear cells (MNC) from healthy donors were isolated from peripheral blood by Ficoll Hypaque density centrifugation. T lymphocytes (used in the experiments depicted in Fig 4) were isolated as the fraction of small lymphocytes (containing over 90% CD3' cells and less than 1% CD14+ cells) from the peripheral blood of healthy donors by centrifugal elutriation as described previously.26 Alternatively, T cells (used in the experiments described in Tables  3, 4 , and Fig 7) were purified by negative depletion using MoAb against CD20, CD56, CDllb, and HLA-DR and goat antimouse IgG-coated magnetic Dynabeads (Dynal, Oslo, Norway). The resulting population consisted of over 96% CD3+ cells, less than 1% CD20' cells or CD14+ cells, and less than 3% CD56+ cells. MNC and T cells were used either directly or after cryopreservation. Cell viability of all populations used was greater than 90% as detected by trypan blue dye exclusion.
Establishment of immortalized BNS cell lines. NS parent cells were cultured overnight in the presence of a B95-8 EBV supernatant. The next day, cells were washed extensively and seeded at a concentration of io5 cells per well in medium containing 15% fetal calf serum. Cell cultures were refreshed every week, and, after 5 weeks, cell growth was observed in 8 of 96 wells seeded. The cells in these wells were cultured separately to yield eight cell lines termed BNS 1, BNS2-1 through BNS2-7. BNS cell lines, but not NS cells, expressed endogenous EBV, as analyzed by polymerase chain reaction (PCR) amplification of a 240-bp BamHlW fragment of the EBV genome (data not shown). The growth rate of BNSl was much slower than that of the other BNS cell lines (doubling time of approximately 5 days v 3 days).
Cell lines. Established BNS cell lines, as well as JY, JVM-3, Jijoye, and NC 37 B-cell lines, were propagated in Dulbecco's modified minimal essential medium supplemented with 10% fetal calf serum and antibiotics. The 3T6 fibroblast cell line, transfected with CD32 (Fc RyII), kindly provided by Dr M. de Boer, was propagated in Iscove's medium plus 10% fetal calf serum and antibiotics.
Preculture of NS cells with anti-CD40 and rlL-4. NS cells were cultured at 2 X IO6 cells per well on a cell layer consisting of irradiated 3T6KD32-transfected fibroblasts (seeded at 0.5 X lo6 per well) in the absence or presence of MoAb 89 (anti-CD40) at 0.5 pg/mL final concentration and/or rIL-4 (50 U/mL). After 3 days of culture, cells were washed extensively, before being used in functional or phenotypic assays.
Electronmicroscopy. NS cells and BNS cell lines were fixed in glutaraldehyde followed by OsO,, stained, and embedded according to routine procedures. Thin sections were examined using a Philips CM10 electron microscope (Philips, Eindhoven, The Netherlands).
Immunojuorescence assay. Surface marker analysis of cells stained with MoAb and fluorescein isothiocyanate (F1TC)-labeled goat F(ab), antimouse Ig was determined by FACScan analysis (Becton Dickinson), as described previously?' Surface antigen expression by B cells in mixed lymphocyte cultures was determined by double fluorescence labeling with primary MoAb and phycoerythrin (PE)-labeled goat antimouse IgG, followed by incubation in normal mouse serum and anti-CD20-FITC. Surface markers were then analyzed on CD20+ gated cells. Analysis of T-cell surface markers in mixed lymphocyte cultures was performed by gating for CD20-cells or by fluorescence-labeling using primary MoAb in combination with PE-labeled anti-CD3 in the last step of the double fluorescence assay and gating the CD3' cells.
Southern blot analysis. High molecular weight DNA from fresh and cultured cells was prepared according to standard proced~res.~" DNA (10 Kg) was digested with BamHI and Bgl I1 restriction enzymes (Boehringer-Mannheim, Mannheim, Germany) and was sizefractionated by 0.6% agarose gel electrophoresis. DNA was transferred to nitrocellulose membranes." The membrane was saturated, prehybridized, and washed as described previously." Blots were hybridized with a 3ZP-random-oligonucleotide-labeled Ig heavychain JH probe (kindly provided by Dr T. Honjo, Kyoto University, Japan)4' and a C, light-chain probe (a gift of Dr Ph. Leder, Harvard Medical School)?' Hybridizing DNA was visualized by autoradiography (Kodak X-Omat; Eastman Kodak Company, Rochester, NY) with intensifying screens. 
RESULTS
Morphology of NS cells m d BNS cell litres. In contrast to the centrocytic appearance of the NS cells (Fig IA) , cultured BNSl cells were typical in that they were homogeneously enlarged ( Fig IB) . BNS2-7 cells. as prototype for the BNS2 series and EBV-transformed B-cell lines from normal donors, were large blasts of variable diameter (Fig IC) .
Phetrowpic nnnlysis. Surface marker analysis of NS cells. BNSl and BNS2-7 cell lines (Table I ) showed that all cell populations were IgM-. IgA-, K-positive. and IgD-, IgG-, X-negative and that they expressed the pan-B-cell antigens CD19 and CD20. as well as HLA-DR and HLA class I antigens. A similar pattern of antigen expression was found for the other BNS cell lines (data not shown). A number of differentiation antigens were distinctively expressed by the various cell populations, eg, CD9. CD23, CD24 and PCA-I. indicating that NS cells and BNS cell lines may represent different activation or differentiation states. In general, this pattern of expression of differentiation antigens was stable over several months. The phenotype of BNSZ-7 was typical for that of the other cell lines of the BNS2 series (data not shown). To determine whether the BNS cell lines were of neoplastic origin, reactivity was tested with two MoAbs, N 12 and N 13, recognizing different epitopes of the parent Ig id (A. Hekman, unpublished). Fluorescence-activated cell sorter (FACS) analysis (Fig 2) showed that all BNS cell lines, as well as the parent NS cell population. were positive for both NI2 and NI 3. indicating the clonal origin of the cell populations.
I g J H nrd K getre renrrntr,qement. Hybridization of BgI 11-and ButnHI-digested DNA with the JH and C, probe. respectively. showed identical rearrangements in the BNS cell lines compared with the NS peripheral blood lympho- degree. On the other hand, NS cells were able to stimulate MNC, but failed to elicit any response in the purified T cells. The purity of the latter cell population was confirmed by its failure to proliferate in response to Con A. These data suggested that, in comparison to NS cells, cells of the BNS cell lines expressed higher levels of accessory molecules involved in allostimulation.
Regulated expression of adhesion receptors on NS and BNS2-7 cells. To directly investigate this hypothesis, NS cells and BNS2-7 cell line cells were tested for expression of a panel of adhesion receptors. As shown in Table 2 , the most prominent difference between NS cells and BNS2-7 cells was the higher expression by BNS2-7 cells of LFA-3 and ICAM-I, molecules known to be important in B-cell/Tcell interactions.".' The functional importance of these molecules for allostimulation by NS cells and BNS2-7 cells was examined in additional experiments. As shown in Fig 5, both
LFA-3 and ICAM-I were strongly upregulated on NS cells during allo-MLR. Also, on both NS and BNS2-7 stimulator cells, upregulation of the L16 epitope of LFA-129.M was observed, indicating that, during MLR, LFA-I had been activated and bidirectional signaling had taken place. As shown in Table 3 . both on the stimulator and the responder cells, LFA-la, L16, and ICAM-l antigens were upregulated in a coordinated fashion, to a higher level during MLR with MNC than during MLR with purified T cells. In addition, when accessory cells were present during MLR, responder T cells expressed higher levels of HLA-DR, indicative of a more activated state ( Table 3) . Regulated expression of costimulaton~ molecules on NS and BNS2-7 cells. Because B7-1/CD80, B7-2/CDS6, and CD40 antigens and their ligands, have been implicated as important accessory structures for cognate and contact-dependent interactions between B and T lymphocytes,"' we tested the expression of these antigens before and after cocultivation in allo-MLR. As shown in a representative experiment in Table 4 , fresh, uncultured NS cells expressed CD40, but completely failed to express B7-1/CD80 and B7-2/CD86, whereas BNS2-7 cells abundantly expressed all three rnolecules. However, on coculture in allo-MLR, expression of B7-1/CD80 and B7-2/CD86 was induced on the NS cells. The average percentage of positive cells t SD in the CD20' gated population in four to five experiments was, for B7-1/ CDSO, 3.2 f 1.6, 18.7 5 4.1, and 9.8 t 4.6 for NS fresh, NS + MNC, and NS + T, respectively: for B7-2/CD86, these figures were 3.5 f 1.7, 33.4 2 0.1, and 11.7 2 1.9, respectively, for two experiments, indicating that cocultiva- tion with both MNC and T cells (although in the latter situation to a lesser degree) resulted in significant upregulation of the number of B7-1/CD80' and B7-2/CD86-cells. In addition, enhanced antigen density of B7-2/CD86 and CD40 was observed after cocultivation of NS cells with MNC. compared with cocultivation with purified T lymphocytes. As shown in Table 4 . in the same allo-MLR. T lymphocytes. constitutively expressing CD28. were induced to express enhanced levels of CD40L when cocultured with BNS2-7 cellline cells as compared with NS cells. In the CD.7-gated population in two to three experiments. the average percentage of B7-I/CD80' cells f SD was 4. Table S , allostimulation of MNC by NS cells, but not by BNS2-7 cells, was inhibited by anti-LFA-1, whereas both stimulators required LFA-3 mediated contact. In addition, the MLR response was partially inhibited by anti-B7-I/CD80 and completely by CTLA4Ig ( Table 5 ), suggesting that other CTLA4 ligands, possibly B7-2/CD86, may also be involved in interactions For 
DISCUSSION
In this report, we describe the establishment of B-cell lines derived from the neoplastic cells from a patient with follicular B-NHL. These cell lines were used to study the requirements for allogeneic T-cell activation by B-NHL cells. The results indicate that T-cell/B-lymphoma cell interactions involve bidirectional signaling through adhesion and costimulatory molecules, which results in their mutual activation.
The BNS cell lines showed a pattern of id+ Ig surface expression and Ig heavy-and light-chain gene rearrangement, identical to that of the parent NS cell population. This confirmed that they were derived from the same neoplastic B-cell clone. On incubation in the presence of EBV, independent BNS cell growth was observed in eight wells, indicating that the neoplastic B cells of this B-NHL patient were relatively readily transformed by EBV. The BNS cell lines, in contrast to the NS cells, showed endogenous expression of EBV. Therefore, it seems likely that true transformation, instead of superinduction by EBV, has occurred. Others have occasionally succeeded in the generation of established non-Burkitt's B-NHL cell line^^'.^ and we previously reported on the establishment of an id' B-NHL cell line by fusion with a B-blastoid cell line.47
We used allostimulation as an in vitro model to study the costimulatory function of the neoplastic B cells. Resting B cells are known to be poor antigen-presenting We found that NS cells did not stimulate purified T cells, but that they were capable of eliciting a response in MNC. This suggested that accessory cells were required to induce a Tcell response. Monocytes were found to only partially restore T-cell proliferation to NS cells (data not shown), suggesting that other cell types present in the MNC population, such as dendritic cells:' may also have contributed to the induction of the T-cell proliferative response.
The capability of the BNS cell lines to induce a response of purified T cells, in contrast to NS cells independently of the presence of accessory cells, indicated that they may possess higher levels of accessory molecules andor produce higher levels of cytokines important for allostimulation. Whereas BNS2-7 in this study was not analyzed for cytokine expression, we have previously shown that B-NHL cells, induced to grow as an established cell line, are capable of secreting IL-1, which mediated costimulation for T lymphocytes and B-NHL cell differentiati~n.~~ In addition to cytokines, adhesion receptors are essential for optimal B-cell/T-cell interactions by providing both adhesion and signalling f~nction.~.' Analysis of adhesion receptors on BNS2-7 cells compared with NS cells, indicated an elevated expression of LFA-3 and ICAM-1 surface antigens. These adhesion molecules were upregulated on NS cells under conditions that show functional stimulator activity, viz. cocultivation with MNC. Interactions between LFA-1 and ICAM-1 have been found to depend not only on the level of ICAM-1 expression, which is highly ~a r i a b l e ,~~.~~. " but also on the expression and state of activation of recognize a conformational change in the LFA-1 molecule, associated with its state of a~tivation.~~ Expression of the L16 epitope on both NS cells and BNS 2-7 cells during MLR (Fig 5) , indicated that LFA-1 had been activated on the stimulator B cells.
To further examine the role of LFA-MCAM-l interactions in MLR, the expression of LFA-1, L1 6, and ICAM-1 was determined on both NS cells and T cells. As shown in Table 3 , a lower level of cell activation occurred after cocultivation with purified T cells than after coculture with MNC. Differences in upregulation of LFA-1, L16, and ICAM-1 were apparent on both responder and stimulator cells, indicating a coordinated regulation of adhesion receptors on both partners in MLR. Moreover, the induction of the L16 epitope, even on the activated cells of the BNS2-7 cell line, reflects that reciprocal signaling takes place by molecules induced on the responder T cells. These data stress the bidirectional nature of signaling pathways between B cells and T cells in allo-MLR."
Evidence for functional involvement of adhesion receptors was obtained by blocking cell-cell interactions in mixed lymphocyte cultures. Allostimulation by both NS and BNS2-7 cells required LFA-3-mediated contact. However, despite comparable expression of LFA-1 and upregulation of L16 on both NS and BNS2-7 cells, only allostimulation by resting NS cells was dependent on LFA-1. We previously found In addition, B7-1/CD80, B7-2/CD86, and CD40 antigens have been implicated as essential molecules for T-cell costimulation." Whereas human B-NHL have been reported to express B7-1/CD80:3.54 fresh NS cells did not express B7-1/CD80 or B7-2/CD86, unless cocultured in allo-MLR, which also enhanced CD40 expression (Table 4 ). This suggested that B lymphoma cells are able to functionally express costimulatory molecules. This was confirmed by the high expression of these molecules on the clonally activated BNS2-7 cells and by blocking experiments that showed that not only B7-1, but also other CTLA4 ligand(s), presumably including B7-2/CD86, were functionally active on the NS and BNS2-7 cells. Interestingly, during allo-MLR, the neoplastic B cells, particularly the highly activated BNS2-7 cellline cells, in return were found to stimulate the responder T cells to express B7-KD80, B7-2/CD86, and CD4OL antigens (Table 4) . Most likely, the high expression of B7-l/ CD80 and B7-2/CD86 antigens on BNS2-7 cells, which facilitates interaction with CD28/CTLA4 on interacting T cells, is important for upregulation of CD40L. 55 From these experiments, it can be concluded that the state of activation and, more specifically, the state of expression of costimulatory molecules may determine a cascade of functional interactions between T cells and B-NHL cells. Accessory cells, such as monocytes or dendritic cells, can express B7-1/CD80 and B7-2/CD86 antigens,I4 suggesting that these cell types, instead of the NS cells themselves, may have provided the required costimulus during MLR with MNC. However, additional data showed that blocking the specific activation of NS cells by anti-id MoAb prevented the induction of the proliferative response of MNC, suggesting that accessory cells present in the MNC population were only involved to start the cascade of cell activation (data not shown).
The observation that NS cells, in contrast to BNS2-7 cells, required the presence of accessory cells to stimulate allogeneic T cells to proliferate may be explained by the failure of NS cells to sufficiently express both adhesion and costimulatory molecules required for T-cell activation. Indeed, NS cells precultured in the presence of anti-CD40 plus rIL-4, or rIL-4 only, were perfectly capable of activating purified T lymphocytes. On these precultured NS cells, B7-1/CD80 was induced, whereas expression of ICA"1 and HLA-DR was unaffected or even somewhat decreased, respectively (see Fig 6) . Moreover, the proliferative responses of T cells to anti-CJMO/rIL-4 precultured NS cells, as to BNS2-7 cells, could be blocked to a large extent by antibody to B7-KD80 (Fig 7) . These data showed that the B-NHL cells themselves were capable of providing costimulation and that at least B7-1/CD80 played an important role in this interaction.
Earlier studies reported on CD40 mediated activation of B-CLL cells5G59 and CD40-induced B-NHL cell growth.6o Our data indicate that also on B-NHL cells, engagement of CD40 triggers the functional expression of B7-1/CD80, as has been reported for B-CLL.27*28 Furthermore, our data show that rIL-4 mediates the upregulation of B7-1/CD80 expression on B-NHL cells, as has been reported for normal B cells.6L Similar results on CD40 engagement of B-NHL cells from two other patients (data not shown), suggest that these costimulatory mechanisms are functional in B-NHL cells in vitro and warrant further studies to reciprocal interactions between B-lymphoma cells and T lymphocytes.
